Recombinant activated factor VII for exsanguinating haemorrhage post bilateral lung transplantation for extra-corporeal lung support-dependent respiratory failure

Anaesthesia and Intensive Care

Volumn 31, Issue 4, 2003, Pages 465-469

  Lucey, M A ^a   Myburgh, J A ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

Haemorrhage: recombinant activated factor VII, extracorporeal, membrane oxygenation, acute respiratory distress syndrome, lung transplantation, tamponade

Indexed keywords

HEPARIN; METHYLPREDNISOLONE; NITRIC OXIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOT; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CASE REPORT; EMERGENCY SURGERY; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; HEART TAMPONADE; HEMOSTASIS; HUMAN; INTENSIVE CARE UNIT; LUNG GAS EXCHANGE; LUNG HEMORRHAGE; LUNG TRANSPLANTATION; MALE; MEDIASTINUM; POSTOPERATIVE HEMORRHAGE; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0041421232     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0303100418     Document Type: Article

References (20)

1. Collins JA. Problems associated with massive transfusion of stored blood. Surgery 1974; 75:274-295.
2. Miller RD, Robbins TO, Tong MJ, Barton SL. Coagulation defects associated with massive blood transfusions. Ann Surg 1971; 174:794-801.
3. Hedner U. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Thromb Haemost 1999; 82:531-539.
4. Key NS, Aledort LM, Beardsley D et al. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 1998; 80:912-918.
5. White B, O'Connor H, Smith OP. Successful use of recombinant factor VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency. Blood Coagul Fibrinolysis 2000; 11:155-157.
6. Cheung PY, Sawicki G, Salas E, Etches PC, Schulz R, Radomski MW. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med 2000; 28:2584-2590.
7. Napoli VM, Symbas PJ, Vroon DH, Symbas PN. Autotransfusion from experimental hemothorax: levels of coagulation factors. J Trauma 1987; 27:296-300.
8. Holleufer RF, Von Bormann B. Continuous autotransfusion system (CATS-Fresenius) Vs Dideco autotransfusion system (Autotrans-Dideco). First clinical results with a new continuous operating autotransfusion device in vascular surgery. Br J Anaesth 1995; 74:Suppl 1:A64.
9. Sieunarine K, Lawrence-Brown MMD, Goodman MA, Prendergast FJ, Rocchetta S. Plasma levels of the lipid mediators, leukotriene B4 and lyso platelet-activating factor, in intraoperative salvaged blood. Vox Sang 1992; 63:168-171.
10. Hedner U. NovoSeven as a universal haemostatic agent. Blood Coagul Fibrinolysis 2000; 11:Suppl 1:S107-111.
11. Makris M, Watson HG. The management of coumarin-induced over-anticoagulation. Br J Haematol 2001; 114:271-280.
12. Puetz JJ, Bouhasin JD. Use of recombinant factor VIIa to control bleeding in an adolescent male with severe hemophilia A, HIV, thrombocytopenia, hepatitis C and end-stage liver disease. Am J Hosp Palliat Care 2002; 19:277-282.
13. Moisescu E, Ardelean L, Simion I, Muresan A, Ciupan R. Recombinant factor VIIa treatment of bleeding associated with acute renal failure. Blood Coagul Fibrinolysis 2000; 11:575-577.
14. Slappendel R, Huvers FC, Benraad B, Novakova I, van Hellemondt GG. Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia. Anesthesiology 2002; 96:1525-1527.
15. Hendriks HG, van der Maaten JM, de Wolf J et al. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001; 93:287-289.
16. Lisman T, Leebeek FW, Meijer K, Van Der Meer J, Nieuwenhuis HK, De Groot PG. Recombinant factor VIIa improves clot formation but not fibrinolytic potential in patients with cirrhosis and during liver transplantation. Hepatology 2002; 35:616-621.
17. Tarantino MD, Aberle R. Recombinant factor VIIa (NovoSeven) for post-prostatectomy hemorrhage in a patient with type I von Willebrand disease. Am J Hematol 2001; 68:62-63.
18. Martinowitz U, Kenet G, Segal E et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 54:431-438.
19. Martinowitz U, Holcomb JB, Pusateri AE et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 2001; 50:721-729.
20. http://www.factorviia.com (2002)